Sign in

CIK 0001159036 · Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880488686
Phone
(858) 794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,884,955
in 5 filings, $19.9M under 10b5-1 plans

Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-24 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −4,489 $53.11 $238K 749,230
2025-06-24 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −15,511 $53.91 $836K 733,719
2025-06-24 Torley Helen PRESIDENT AND CEO Option exercise · Option to Purchase Common Stock 10b5-1 −20,000 $8.11 $162K 316,569
2025-06-23 Torley Helen PRESIDENT AND CEO Option exercise 10b5-1 +20,000 $8.11 $162K 753,719
2025-06-23 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −20,000 $52.57 $1.1M 733,719
2025-06-23 Torley Helen PRESIDENT AND CEO Option exercise · Option to Purchase Common Stock 10b5-1 −20,000 $8.11 $162K 336,569
2025-06-20 Torley Helen PRESIDENT AND CEO Option exercise 10b5-1 +20,000 $8.11 $162K 753,719
2025-06-20 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −20,000 $52.96 $1.1M 733,719
2025-06-20 Torley Helen PRESIDENT AND CEO Option exercise · Option to Purchase Common Stock 10b5-1 −20,000 $8.11 $162K 356,569
2025-06-12 Snyder Mark Howard SVP, CHIEF LEGAL OFFICER Option exercise +5,035 33,524
2025-06-12 Snyder Mark Howard SVP, CHIEF LEGAL OFFICER Shares withheld for taxes −2,711 $54.54 $148K 30,813
2025-06-12 Snyder Mark Howard SVP, CHIEF LEGAL OFFICER Option exercise · Restricted Stock Units −5,035 15,102
2025-05-01 Posard Matthew L. Director Grant or award +4,165 74,039
2025-05-01 Posard Matthew L. Director Grant or award · Option to Purchase Common Stock +5,750 5,750
2025-05-01 Miyashita Akiko Moni Director Grant or award +4,165 24,937
2025-05-01 Miyashita Akiko Moni Director Grant or award · Option to Purchase Common Stock +5,750 5,750
2025-05-01 Krishnan Mahesh Director Grant or award +4,165 10,666
2025-05-01 Krishnan Mahesh Director Grant or award · Option to Purchase Common Stock +5,750 5,750
2025-05-01 Henderson Jeffrey William Director Grant or award +4,165 32,776
2025-05-01 Henderson Jeffrey William Director Grant or award · Option to Purchase Common Stock +5,750 5,750

Page 18 of 26 · 513 trades